BEATW Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-0.500.0% YoY
Profit margin0.0%HEALTHCARE
Market cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
-164.2%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
Beta
Last earnings
Jun 30, 2021 · Estimate $0.00 · Reported $-0.26
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About Heartbeam Inc. Warrant

Heartbeam Inc. Warrant (BEATW) offers a compelling investment opportunity tied to Heartbeam Inc., an innovative healthcare technology company dedicated to revolutionizing cardiac diagnostics through artificial intelligence and digital health solutions. The company's advanced platform enhances diagnostic accuracy for myocardial infarctions, promoting timely medical interventions that can drastically improve patient outcomes. In a landscape where demand for remote monitoring and telehealth services is surging, Heartbeam stands poised to leverage significant market growth, positioning BEATW as a…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
NONE
Fiscal year end
December
Latest quarter
Mar 31, 2026
Shares outstanding$0
52W high$0.56
52W low$0.03

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer